• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

EDITORIALI - Editorials

Volume:

Biochimica Clinica 2019; 43(1) e1-e3

Published on-line:

September 6, 2023

DOI:

10.19186/BC_2018.051

Download in PDF:
Authentication required

Un caso di linfoadenopatia, epatosplenomegalia e triptasi elevata

AUTHORS

Daniela Avino, Giovanna Abate, Anna Di Palma, Maria Gerarda Pirofalo, Gemma Morelli, Paolo Danise
Diagnostica Ematologica Presidio Ospedaliero A. Tortora, Pagani (Sa)

ABSTRACT

A case of lymphadenopathy, hepatosplenomegaly and elevated serum tryptase level

A case of lymphadenopathy, hepatosplenomegaly and elevated serum tryptase level. Mastocytosis is a rare clonal disease characterized by neoplastic proliferation of mast cells in one or more organs, frequently skin and bone marrow. Diagnosis and classification of mastocytosis is based on the identification of neoplastic mast cells in according to the morphological, immunophenotypical and/or molecular criteria established by the WHO. For the diagnosis, serum levels of the tryptase which correlate with quantity and activity of mast cells is particulary useful. This case reports about a 60-year-old man with hepatosplenomegaly, modest monoclonal component, reactive lymph node hyperplasia and moderate macrocytic anemia (haemoglobin:129 gr/L). Bone marrow aspiration shows areas of infiltration of atypical mast cells type II and rarely type I with aberrant immunophenotype: CD45++CD117++CD2+CD25+. The tryptase concentration is significantly increased. According to WHO 2008 criteria, diagnosis of systemic mastocytosis is made. Early diagnosis of mastocytosis is pivotal because immunotherapy is often required to reduce the risk of allergic reactions or major bone complications.

REFERENCES